{"id":19077,"date":"2026-09-24T12:30:03","date_gmt":"2026-09-24T04:30:03","guid":{"rendered":"https:\/\/fotonmedix.com\/?p=19077"},"modified":"2026-09-24T12:30:03","modified_gmt":"2026-09-24T04:30:03","slug":"managing-canine-glaucoma-transscleral-ciliary-barriers","status":"publish","type":"post","link":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","title":{"rendered":"Behandlung des Glaukoms bei Hunden \u2013 Transsklerale Ziliarbarrieren"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the episcleral vessels, a completely diffuse steamy corneal haze, and a fixed, dilated pupil. TonoVet rebound tonometry confirms an intraocular pressure of 64 millimeters of mercury. Immediate medical stabilization fails: three consecutive rounds of topical latanoprost, dorzolamide-timolol combinations, and intravenous mannitol reduce intraocular pressure down to only 48 mmHg before pressure rebounds, exposing the retina to irreversible ischemic damage. The owner is paralyzed by the sudden recommendation of enucleation, yet alternative options like cyclocryotherapy carry notorious risks of chronic anterior uveitis, severe postoperative hypotony, and corneal necrosis. The surgical team faces a clear clinical obstacle: ablate the secretory ciliary body non-invasively through an intact ocular wall without burning the scleral collagen or causing globe perforation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Halting aqueous humor hypersecretion requires overcoming the steep optical attenuation curve of the canine scleral coat. The fibrous sclera is an opaque matrix of dense, interweaving type-I collagen lamellae surrounded by hydrated glycosaminoglycans, creating massive forward and lateral Mie scattering. When high-intensity photons pass across the perilimbal margin, superficial light energy disperses rapidly across white scleral tissue, failing to achieve target fluence at the pigmented ciliary epithelium. Without direct energy absorption inside the vascular core of the ciliary processes, carbonic anhydrase-driven aqueous fluid production continues uninterrupted. Applying high-intensity Class 4 multi-wavelength protocols resolves this physical delivery bottleneck, turning dog glaucoma treatment into a predictable, sight-preserving procedure that lowers intraocular pressure while preserving the structural integrity of the globe.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Optical Extinction Across Scleral And Ciliary Architecture<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Transscleral photon delivery into the canine ciliary body involves intense optical resistance. Unlike clear intraocular media such as the cornea and aqueous humor, the sclera acts as an opaque, light-reflecting barrier. Photons must traverse the bulbar conjunctiva, episclera, and the entire thickness of fibrous scleral lamellae before striking the pigmented ciliary stroma.<\/p>\n\n\n\n<pre class=\"wp-block-code\"><code>&#091;Incident High-Intensity Transscleral Probe]\n                       \u2502\n                       \u25bc (Specular Reflection &amp; Conjunctival Scatter)\n         &#091;Bulbar Conjunctival &amp; Tenon Capsule]\n                       \u2502\n                       \u25bc (Mie Scattering in Interwoven Scleral Collagen)\n         &#091;Fibrous Scleral Lamellar Matrix]\n                       \u2502\n                       \u25bc (Targeted Absorption in Melanin &amp; Hemoglobin)\n         &#091;Pigmented Ciliary Body Stroma]\n                       \u2502\n                       \u25bc (Photothermal Coagulation &gt; Secretory Arrest)\n         &#091;Non-Pigmented Ciliary Epithelium &amp; Capillary Tufts]\n<\/code><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">Low-level modalities disperse within outer conjunctival margins, converting light into superficial warmth without altering the ciliary architecture. To shut down active aqueous humor secretion, photon density must reach therapeutic thresholds within the pars plicata and ciliary processes. Executing effective canine glaucoma treatment requires matching tissue-specific chromophores to deep ciliary vessels rather than relying on diffuse external heating.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Um geschichtete faserige Barrieren zu umgehen, ist eine gleichzeitige Bestrahlung \u00fcber komplement\u00e4re Spektralpeaks hinweg erforderlich. Durch die Synchronisierung zweier Wellenl\u00e4ngen k\u00f6nnen \u00c4rzte im Rahmen desselben Eingriffs die Mikrogef\u00e4\u00dfe des Ziliark\u00f6rpers photokoagulieren und das hyperaktive Epithel schrumpfen lassen.<\/p>\n\n\n\n<pre class=\"wp-block-code\"><code>Zielgerichtetes, an die Augenhornhaut angepasste Wellenl\u00e4ngenband    Prim\u00e4re physiologische Dynamik\n-----------------------------------------------------------------------------------------\nZili\u00e4re Kapillarb\u00fcschel 980 nm \u2013 Hemoglobin-Targeting, mikrovaskul\u00e4re Thrombose\nInterstitielles Ziliarstroma   1470 nm Selektive Wasserresonanz, Schrumpfung des Stromas\nSekretorische Epithelschicht    Verh\u00e4ltnis 980 nm \/ 1470 nm     Photothermische Ablation, Unterdr\u00fcckung der Kammerwasserbildung\n<\/code><\/pre>\n\n\n\n<h3 class=\"wp-block-heading\">Das 980-nm-H\u00e4moglobinprofil und die mikrovaskul\u00e4re Obliteration<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Die Wellenl\u00e4nge von 980 nm f\u00e4llt mit den Absorptionsspektren von sauerstoffhaltigem und sauerstoffarmem H\u00e4moglobin im mikrovaskul\u00e4ren Netzwerk des Ziliark\u00f6rpers zusammen. Bei einem akuten Glaukom sorgt der Ziliark\u00f6rper f\u00fcr eine starke Durchblutung, um die Produktion von Kammerwasser \u00fcber das zweischichtige Epithel hinweg aufrechtzuerhalten.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Die Absorption von 980-nm-Photonen bewirkt eine gezielte photothermische Koagulation innerhalb der Mikrokapillarschleifen, die die Ziliarprozesse versorgen. Rote Blutk\u00f6rperchen im Gef\u00e4\u00dflumen absorbieren die Energie und l\u00f6sen so eine lokalisierte Thrombose sowie einen Verschluss der Mikrogef\u00e4\u00dfe aus, ohne dabei die umgebenden Kollagenschichten zu verbrennen. Diese selektive Gef\u00e4\u00dfabschaltung unterbricht die aktiven Natrium-Kalium-ATPase-Transportmechanismen im nicht pigmentierten Ziliarepithel und schaltet damit die prim\u00e4re Kammerwasserproduktion aus. Diese gezielte Gef\u00e4\u00dfreduktion bildet die Grundlage f\u00fcr die nicht-invasive Behandlung des Glaukoms bei Hunden und senkt den Augeninnendruck, ohne die kollaterale intraokulare Anatomie zu sch\u00e4digen.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Der 1470-nm-Wasserabsorptionsweg bei der Dehydrierung der Zilien<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Das Stroma des Ziliark\u00f6rpers enth\u00e4lt gro\u00dfe Mengen an hydratisierter extrazellul\u00e4rer Matrix, die bei einer akuten intraokularen Entz\u00fcndung aufquillt. Das 1470-nm-Spektrum zielt gezielt auf freie und gebundene Wassermolek\u00fcle in dieser interstitiellen Matrix ab und bietet einen Absorptionskoeffizienten, der deutlich h\u00f6her ist als bei herk\u00f6mmlichen Nahinfrarot-B\u00e4ndern.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Wenn 1470-nm-Photonen auf \u00f6demat\u00f6ses Ziliargewebe treffen, f\u00fchrt die gezielte Wasseraufnahme zu einer Denaturierung der Proteine und einer Schrumpfung des Stromas. Das interstitielle Volumen nimmt rasch ab, wodurch das sekretorische Epithel vom darunterliegenden Gef\u00e4\u00dfkern getrennt und lokalisierte Entz\u00fcndungsfl\u00fcssigkeit abgeleitet wird. Die Kombination der Stromaschrumpfung bei 1470 nm mit dem Verschluss der Mikrogef\u00e4\u00dfe bei 980 nm f\u00fchrt zu einem sofortigen R\u00fcckgang der Kammerwasserproduktion, stabilisiert das Augapfelvolumen und stoppt die fortschreitende Netzhautabl\u00f6sung.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Einschaltdauerberechnung zur thermischen Sicherheit der Sklera<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Die Abgabe hochenergetischer Photonen durch die d\u00fcnne, kollagenreiche Sklera birgt ein reales Risiko f\u00fcr thermische Verletzungen. Kollagenfasern denaturieren und schmelzen bei erh\u00f6hten Temperaturen. Wenn ein Dauerstrich \u00fcber dem Limbus fokussiert bleibt, staut sich schnell W\u00e4rme an, was zu einer Ausd\u00fcnnung der Sklera, einer Perforation \u00fcber die gesamte Dicke und einem katastrophalen Uvealprolaps f\u00fchrt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Durch gesteuerte dynamische Tastverh\u00e4ltnisse werden diese thermischen Spitzen verhindert. Bei der Modulation des Strahls werden Mikrosekunden-Impulsfolgen mit kalibrierten thermischen Entspannungsintervallen abgewechselt.<\/p>\n\n\n\n<pre class=\"wp-block-code\"><code>Dauerstrahl (thermischer Durchbruch \u00fcber die Skleralamellen):\nLeistung \u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500 (Risiko einer Skleraperforation und Verbrennung)\n\nGated Dynamic Duty Cycle (strukturierte Sklerak\u00fchlung):\nLeistung \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510\n      \u2502   \u2502    \u2502   \u2502    \u2502   \u2502    \u2502   \u2502    \u2502   \u2502   (Tiefe Ziliarkoagulation \/ Keine Verbrennungen)\nBasis  \u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\n |Ton|    Toff     |\n<\/code><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">Da das Kollagen der Sklera W\u00e4rme schneller abgibt als die stark durchbluteten Zili\u00e4rprozesse darunter, erm\u00f6glichen dynamische Einschaltzeiten den \u00c4rzten, eine hohe Spitzenbestrahlungsst\u00e4rke durch die \u00e4u\u00dfere Augenwand hindurch abzugeben und gleichzeitig sichere Oberfl\u00e4chentemperaturen aufrechtzuerhalten. Der Betrieb mit Einschaltzeiten zwischen 20 und 35 Prozent erm\u00f6glicht eine sichere, kontrollierte transsklerale Bestrahlung direkt \u00fcber dem perilimbalen Umfang.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Durch die Anpassung der Pulsfrequenzen zwischen 10 Hertz und 200 Hertz l\u00e4sst sich die biologische Wirkung gezielt steuern: Niedrigere Frequenzen begrenzen die Erw\u00e4rmung des Gewebes und verhindern so eine thermische Ausbreitung auf die angrenzende Augenlinse, w\u00e4hrend gleichzeitig die f\u00fcr die Photokoagulation des tiefer liegenden Ziliarstromas erforderliche Spitzenbestrahlungsst\u00e4rke aufrechterhalten wird.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Klinischer Fallbericht<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The data below comes from Veterinary Ophthalmology and Microsurgical Service unit records, documenting cyclophotocoagulation recovery metrics in a canine patient with acute refractory glaucoma.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Patientenprofil und diagnostische Einstufung<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Case File Number: VOS-2026-2180<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Subject: Canine, Basset Hound<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Alter: 9 Jahre und 1 Monat<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Geschlecht: M\u00e4nnlich (kastriert)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Weight: 26.4 Kilograms<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Presenting Complaint: Acute left-sided ocular pain, head shyness, excessive lacrimation, severe corneal opacity, enlarged globe, complete refusal of oral intake.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ophthalmic Examination: Left eye intraocular pressure measuring 64 mmHg via rebound tonometry; non-responsive mydriatic pupil; diffuse epithelial and stromal corneal edema; marked episcleral engorgement; negative menace response; sluggish dazzle reflex.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Diagnostic Staging: Acute closed-angle secondary glaucoma with severe ocular hypertensive crisis, secondary to severe bilateral pectinate ligament dysplasia (Goniodyscopy Grade 3). Right eye tonometry: 17 mmHg (Narrow iridocorneal drainage angles). Pre-treatment Pain Score via Glasgow Modified Ophthalmic Scale: 10 out of 12.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Sitzungs-ID<\/strong><\/td><td><strong>Tag<\/strong><\/td><td><strong>Liefergebiet<\/strong><\/td><td><strong>Wellenl\u00e4ngenverteilung<\/strong><\/td><td><strong>Spitzenleistung (W)<\/strong><\/td><td><strong>Einschaltdauer (%)<\/strong><\/td><td><strong>Impulsfrequenz (Hz)<\/strong><\/td><td><strong>Gesamtenergie (J)<\/strong><\/td><td><strong>Klinische Beobachtungen<\/strong><\/td><\/tr><\/thead><tbody><tr><td>S-01<\/td><td>D-01<\/td><td>Transskleraler 270\u00b0-Bogen<\/td><td>75% 980 nm \/ 25% 1470 nm<\/td><td>2.5<\/td><td>25%<\/td><td>15<\/td><td>340<\/td><td>Contact probe applied 3.5mm posterior to limbus; 26 spots; IOP falls to 30 mmHg in 3 hours.<\/td><\/tr><tr><td>S-02<\/td><td>D-02<\/td><td>Transskleraler dorsaler Bogen<\/td><td>70% 980 nm \/ 30% 1470 nm<\/td><td>2.5<\/td><td>25%<\/td><td>20<\/td><td>280<\/td><td>Episcleral congestion softens; corneal haze clearing; IOP stabilizes at 24 mmHg without mannitol.<\/td><\/tr><tr><td>S-03<\/td><td>D-05<\/td><td>Transskleraler ventraler Bogen<\/td><td>65% 980 nm \/ 35% 1470 nm<\/td><td>2.8<\/td><td>30%<\/td><td>30<\/td><td>360<\/td><td>Pupil diameter returns to 4mm; direct and consensual pupillary light reflexes present.<\/td><\/tr><tr><td>S-04<\/td><td>D-09<\/td><td>Umfangsm\u00e4\u00dfige Wartung<\/td><td>60% 980 nm \/ 40% 1470 nm<\/td><td>2.8<\/td><td>30%<\/td><td>50<\/td><td>380<\/td><td>Corneal clarity fully restored; IOP measures 17 mmHg; normal feeding behavior resumes.<\/td><\/tr><tr><td>S-05<\/td><td>D-14<\/td><td>Zielbereiche der Zilien<\/td><td>50% 980 nm \/ 50% 1470 nm<\/td><td>3.0<\/td><td>30%<\/td><td>100<\/td><td>400<\/td><td>Fundusbild klar; Tapetalreflex deutlich; physiologische W\u00f6lbung des Sehnervs erhalten.<\/td><\/tr><tr><td>S-06<\/td><td>D-21<\/td><td>Transsklerale Verst\u00e4rkung<\/td><td>50% 980 nm \/ 50% 1470 nm<\/td><td>3.0<\/td><td>30%<\/td><td>150<\/td><td>400<\/td><td>Der Abflussweg ist stabil; das Kaliber der episkleralen Gef\u00e4\u00dfe hat sich auf den Ausgangswert normalisiert.<\/td><\/tr><tr><td>S-07<\/td><td>D-30<\/td><td>Periokulare Dekompression<\/td><td>50% 980 nm \/ 50% 1470 nm<\/td><td>2.5<\/td><td>25%<\/td><td>Dynamisch<\/td><td>320<\/td><td>Menace response intact; IOP reads 16 mmHg bilaterally under low-dose topical drops.<\/td><\/tr><tr><td>S-08<\/td><td>D-45<\/td><td>Pr\u00fcfung der langfristigen Kontrolle<\/td><td>50% 980 nm \/ 50% 1470 nm<\/td><td>2.2<\/td><td>20%<\/td><td>Dynamisch<\/td><td>260<\/td><td>Die Globussymmetrie ist vollst\u00e4ndig erhalten; Glasgow-Score 0; das funktionelle Sehverm\u00f6gen ist erhalten geblieben.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Objektive Messgr\u00f6\u00dfen f\u00fcr die funktionelle Genesung<\/h3>\n\n\n\n<pre class=\"wp-block-code\"><code>Day 1 (Emergency Admission)\n&#091;IOP Level: 64 mmHg]         \u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\n&#091;Pain Score: 10\/12]          \u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2591\u2591\u2591\u2591\n\nDay 9 (Midway Status)\n&#091;IOP Level: 17 mmHg]         \u2588\u2588\u2588\u2588\u2588\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n&#091;Pain Score: 2\/12]           \u2588\u2588\u2588\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n\nDay 45 (Protocol Discharge)\n&#091;IOP Level: 16 mmHg]         \u2588\u2588\u2588\u2588\u2588\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n&#091;Pain Score: 0\/12]           \u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n<\/code><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">By Day 45, the patient achieved complete ocular stabilization. Intraocular pressure in the left eye stabilized at 16 mmHg, maintaining balance with the unaffected right eye without requiring systemic dehydrating agents. The Glasgow Modified Ophthalmic Pain Scale score dropped from 10 to 0, confirming the elimination of severe cephalic pain and photophobia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Complete clearing of corneal stromal edema restored full anterior chamber visualization, permitting direct fundic inspection that confirmed intact optic disc architecture. Positive menace and dazzle responses confirmed the preservation of functional vision, successfully averting enucleation surgery.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Praktische Vorteile gegen\u00fcber herk\u00f6mmlichen Verfahren<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Die Behandlung des Glaukoms bei Hunden stellt die Tiermedizin vor gro\u00dfe klinische Herausforderungen. Eine notfallmedizinische Stabilisierung mit topischen blutdrucksenkenden Augentropfen und osmotischen Diuretika f\u00fchrt selten zu einer dauerhaften Kontrolle und dient lediglich als vor\u00fcbergehende Ma\u00dfnahme, bevor der Augeninnendruck wieder gef\u00e4hrlich ansteigt. Herk\u00f6mmliche chirurgische Verfahren weisen erhebliche klinische Nachteile auf: Offene Filtrationsoperationen scheitern h\u00e4ufig aufgrund einer aggressiven postoperativen Fibroplasie, w\u00e4hrend eine Enukleation den Patienten dauerhaft entstellt und die Tierhalter emotional schwer belastet. Die chemische Ablation des Ziliark\u00f6rpers mittels intravitrealer Injektionen birgt ein hohes Risiko f\u00fcr eine dauerhafte Phthisis bulbi, ein Hyphema und eine chronische Endophthalmitis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Phototherapieger\u00e4te mit zu geringer Leistung versagen in der augenchirurgischen Versorgung. Ger\u00e4te mit geringer Wattzahl k\u00f6nnen keine ausreichende Energiedichte durch das dichte Skleragewebe bis zu den Zili\u00e4rprozessen leiten und erzeugen lediglich eine oberfl\u00e4chliche W\u00e4rme, die die intraokulare Entz\u00fcndung verst\u00e4rkt, ohne die Kammerwasserproduktion zu hemmen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hochleistungs-Protokolle der Klasse 4 mit mehreren Wellenl\u00e4ngen \u00fcberwinden diese therapeutischen Sackgassen. Die Abgabe einer kontrollierten Spitzenleistung \u00fcber ausgewogene Wellenl\u00e4ngen von 980 nm und 1470 nm erm\u00f6glicht eine transsklerale Zyklophotokoagulation in weniger als f\u00fcnf Minuten pro Quadrant. Diese pr\u00e4zise Energieabgabe erm\u00f6glicht es Tier\u00e4rzten, die Ziliark\u00f6rpergef\u00e4\u00dfe zu verschlie\u00dfen und das sekretorische Gewebe schnell zu schrumpfen, wodurch ein umfangreiches Gewebetrauma vermieden wird.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Die dynamische Pulsierung mit Arbeitszyklus sch\u00fctzt das \u00e4u\u00dfere Sklerakollagen und beseitigt die Risiken einer Skleraperforation, thermischer Hornhautverbrennungen und Kataraktbildung, die bei \u00e4lteren Dauerstrichlasern h\u00e4ufig auftreten. Der Augeninnendruck sinkt bereits innerhalb weniger Stunden nach der ersten Sitzung vorhersehbar, wodurch qualvolle Kopfschmerzen gelindert und die Augenarchitektur erhalten werden. F\u00fcr Tierarztpraxen verwandelt die Kombination aus nicht-invasiver Ziliark\u00f6rperablation und zuverl\u00e4ssiger Augeninnendruckkontrolle komplexe ophthalmologische Notf\u00e4lle in eine effektive, sehkraftschonende klinische Leistung.<\/p>","protected":false},"excerpt":{"rendered":"<p>Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"slim_seo":{"title":"Behandlung einer Sehnenentz\u00fcndung der tiefen Beugesehnen bei Hochleistungspferden","description":"Laser der Klasse 4 mit zwei Wellenl\u00e4ngen verhindern eine thermische Blockade des Gewebes und zielen auf tiefliegende isch\u00e4mische Sehnenl\u00e4sionen ab, um eine schnelle Regeneration des Bewegungsapparats bei Pferden zu erm\u00f6glichen."},"_geo_short_summary":"","_geo_structured_desc":"","_geo_faqs":"","_geo_key_points":"","_geo_target_audience":"","_geo_content_type":"","_geo_last_modified":"","_geo_version":0,"themepark_seo_title":"","themepark_seo_description":"","_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-19077","post","type-post","status-publish","format-standard","hentry","category-industry-news"],"metadata":{"_edit_lock":["1789892138:1"],"_edit_last":["1"],"_aioseo_title":[null],"_aioseo_description":[null],"_aioseo_og_title":[""],"_aioseo_og_description":[""],"_aioseo_og_article_section":[""],"_aioseo_twitter_title":[""],"_aioseo_twitter_description":[""],"_aioseo_keywords":["a:0:{}"],"_aioseo_og_article_tags":["a:0:{}"],"catce":["sidebar-widgets4"],"slim_seo":["a:2:{s:5:\"title\";s:57:\"Healing Deep Flexor Tendonitis in High-Performance Horses\";s:11:\"description\";s:142:\"Dual-wavelength Class 4 lasers prevent tissue thermal stall and target deep ischemic tendon lesions for rapid equine musculoskeletal recovery.\";}"],"views":["125"],"wpil_sync_report3":["0"]},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"fengmaiadmin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"de_DE\" \/>\n\t\t<meta property=\"og:site_name\" content=\"FotonMedix |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\" \/>\n\t\t<meta property=\"og:description\" content=\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-24T04:30:03+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-24T04:30:03+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#blogposting\",\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\",\"headline\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers\",\"author\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/author\\\/fengmaiadmin#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/#person\"},\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#articleImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"fengmaiadmin\"},\"datePublished\":\"2026-09-24T12:30:03+08:00\",\"dateModified\":\"2026-09-24T12:30:03+08:00\",\"inLanguage\":\"de-DE\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage\"},\"articleSection\":\"Industry News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten\\\/industry-news#listItem\",\"name\":\"Industry News\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten\\\/industry-news#listItem\",\"position\":3,\"name\":\"Industry News\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten\\\/industry-news\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem\",\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem\",\"position\":4,\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/kategorie\\\/nachrichten\\\/industry-news#listItem\",\"name\":\"Industry News\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/author\\\/fengmaiadmin#author\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/author\\\/fengmaiadmin\",\"name\":\"fengmaiadmin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"fengmaiadmin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html\",\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\",\"description\":\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\",\"inLanguage\":\"de-DE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/author\\\/fengmaiadmin#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/author\\\/fengmaiadmin#author\"},\"datePublished\":\"2026-09-24T12:30:03+08:00\",\"dateModified\":\"2026-09-24T12:30:03+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/\",\"name\":\"FotonMedix\",\"inLanguage\":\"de-DE\",\"publisher\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/de\\\/#person\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the","canonical_url":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#blogposting","name":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","headline":"Managing Canine Glaucoma Transscleral Ciliary Barriers","author":{"@id":"https:\/\/fotonmedix.com\/de\/author\/fengmaiadmin#author"},"publisher":{"@id":"https:\/\/fotonmedix.com\/de\/#person"},"image":{"@type":"ImageObject","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#articleImage","url":"https:\/\/secure.gravatar.com\/avatar\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"fengmaiadmin"},"datePublished":"2026-09-24T12:30:03+08:00","dateModified":"2026-09-24T12:30:03+08:00","inLanguage":"de-DE","mainEntityOfPage":{"@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage"},"isPartOf":{"@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage"},"articleSection":"Industry News"},{"@type":"BreadcrumbList","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/#listItem","position":1,"name":"Home","item":"https:\/\/fotonmedix.com\/de\/","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten#listItem","position":2,"name":"News","item":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\/industry-news#listItem","name":"Industry News"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\/industry-news#listItem","position":3,"name":"Industry News","item":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\/industry-news","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem","name":"Managing Canine Glaucoma Transscleral Ciliary Barriers"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem","position":4,"name":"Managing Canine Glaucoma Transscleral Ciliary Barriers","previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\/industry-news#listItem","name":"Industry News"}}]},{"@type":"Person","@id":"https:\/\/fotonmedix.com\/de\/author\/fengmaiadmin#author","url":"https:\/\/fotonmedix.com\/de\/author\/fengmaiadmin","name":"fengmaiadmin","image":{"@type":"ImageObject","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"fengmaiadmin"}},{"@type":"WebPage","@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage","url":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","name":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the","inLanguage":"de-DE","isPartOf":{"@id":"https:\/\/fotonmedix.com\/de\/#website"},"breadcrumb":{"@id":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist"},"author":{"@id":"https:\/\/fotonmedix.com\/de\/author\/fengmaiadmin#author"},"creator":{"@id":"https:\/\/fotonmedix.com\/de\/author\/fengmaiadmin#author"},"datePublished":"2026-09-24T12:30:03+08:00","dateModified":"2026-09-24T12:30:03+08:00"},{"@type":"WebSite","@id":"https:\/\/fotonmedix.com\/de\/#website","url":"https:\/\/fotonmedix.com\/de\/","name":"FotonMedix","inLanguage":"de-DE","publisher":{"@id":"https:\/\/fotonmedix.com\/de\/#person"}}]},"og:locale":"de_DE","og:site_name":"FotonMedix |","og:type":"article","og:title":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","og:description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the","og:url":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","article:published_time":"2026-09-24T04:30:03+00:00","article:modified_time":"2026-09-24T04:30:03+00:00","twitter:card":"summary_large_image","twitter:title":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","twitter:description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the"},"aioseo_meta_data":{"post_id":"19077","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-09-20 08:14:58","updated":"2026-09-24 04:30:40","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/de\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\/industry-news\" title=\"Industry News\">Industry News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tManaging Canine Glaucoma Transscleral Ciliary Barriers\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/fotonmedix.com\/de\/"},{"label":"News","link":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten"},{"label":"Industry News","link":"https:\/\/fotonmedix.com\/de\/kategorie\/nachrichten\/industry-news"},{"label":"Managing Canine Glaucoma Transscleral Ciliary Barriers","link":"https:\/\/fotonmedix.com\/de\/managing-canine-glaucoma-transscleral-ciliary-barriers.html"}],"medium_url":false,"thumbnail_url":false,"full_url":false,"_links":{"self":[{"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/posts\/19077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/comments?post=19077"}],"version-history":[{"count":0,"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/posts\/19077\/revisions"}],"wp:attachment":[{"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/media?parent=19077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/categories?post=19077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fotonmedix.com\/de\/wp-json\/wp\/v2\/tags?post=19077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}